Pandemics & Infectious Diseases
Prevention & Personalised Health
AXA Projects
United Kingdom
Understanding lung dendritic cell function in resistance to influenza: from mouse to human
Understanding better how the flu virus interacts with the human immune system would answer questions about how it manages to evade our defenses. This is the goal of a team led by Prof. Matthew Collin of Newcastle University. They started their investigation at the virus’s first point of contact with our immune system: the lung dendritic cells.
The main role of dendritic cells (DC) is to take up foreign particles invading the body and process them for presentation on the cell surface—a signal that will activate other cells to launch an immune response. Using innovative bioinformatics tools, Collin’s lab identified two subsets of human DC that appear to have distinct functions in resisting infection with influenza A. This was first observed in mouse models, which will also make it possible to determine the exact role of the DC subsets in fighting off the virus. To accomplish this, Collin will use a method called inducible depletion, meaning he will artificially trigger the regression of each of the mouse dendritic cell subsets in question, to determine the effect their absence may have on the immune response to influenza A.
The conclusions drawn from such mouse studies will need to be translated back into humans in order to shed light on the virus’s ability to cause disease in people. Additional tests to achieve this important step will be carried out on human DC grown in the lab, as well as an innovative “humanized” mouse model with human lung DC grafts.
Ultimately, Collin’s research should clarify to a much greater extent the precise role of our lung dendritic cells in launching a defense against influenza A infection. With this knowledge, more relevant strategies could be developed for designing vaccines—a current need that is sure to remain with us into the future.
Influenza on the human doorstep
To add or modify information on this page, please contact us at the following address: community.research@axa.com

Matthew
COLLIN
Institution
Newcastle University
Country
United Kingdom
Nationality
British
Related articles
Pollution
Prevention & Personalised Health
Post-Doctoral Fellowship
Luxembourg
Using New Data Sources to Better Manage Substances of Concern (Soc)
In order to put together an accurate risk management process and drive the appropriate regulatory policies, it is necessary to... Read more

Oona
FREUDENTHAL
Luxembourg Institute of Science and Technology
Prevention & Personalised Health
Pollution
Post-Doctoral Fellowship
Australia
2022.02.27
Understanding Human Exposure to Contaminants of Emerging Concern Through New Biomarkers
Human biomonitoring (HBM) allows the assessment of human exposure to chemicals, by measuring chemicals and their concentration in human tissues... Read more

Chang
HE